The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Bugaenko D.V.

Petrovsky Russian Research Center for Surgery, Moscow, Russia

Fominykh M.V.

Otdelenie kardioreanimatsii i intensivnoĭ terapii FGBU RNTsKh im. akad. B.V. Petrovskogo RAMN, Moskva

Eremenko A.A.

Otdelenie kardioreanimatsii i intensivnoĭ terapii FGBU RNTsKh im. akad. B.V. Petrovskogo RAMN, Moskva

Current percutaneous left ventricular assist devices

Authors:

Bugaenko D.V., Fominykh M.V., Eremenko A.A.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2018;11(3): 35‑40

DOI: 10.17116/kardio201811335

Views: 3662

Downloaded: 164

Download PDF (RU)
Contact the author
Table of contents

CURRENT PERCUTANEOUS LEFT VENTRICULAR ASSIST DEVICES
CURRENT PERCUTANEOUS LEFT VENTRICULAR ASSIST DEVICES

To cite this article:

Bugaenko DV, Fominykh MV, Eremenko AA. Current percutaneous left ventricular assist devices. Russian Journal of Cardiology and Cardiovascular Surgery. 2018;11(3):35‑40. (In Russ.)
https://doi.org/10.17116/kardio201811335

Подписка 2025-2 (Russian Journal of Cardiology and Cardiovascular Surgery)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Case of left ventricular wall aneurysm mani­festation in patient with Marfan syndrome after SARS-CoV-2 re-infection. Russian Journal of Preventive Medi­cine. 2024;(6):88-90

This review is devoted to current percutaneous left ventricular assist devices for short-term support such as intra-aortic balloon pump, Tandem Heart, Impella, and includes detailed description of new pulsatile percutaneous left ventricular assist device PulseCath iVAC 2L. We have briefly discussed the mechanisms of action, hemodynamic benefits, indications and contraindications for these devices. Also we reviewed the results of pivotal trials investigating their use in patients with acute or decompensated heart failure and high-risk percutaneous coronary interventions.

Keywords:

left ventricular assist devices
short-term circulatory support
high-risk percutaneous coronary interventions
acute heart failure
PulseCath iVAC 2L

Authors:

Bugaenko D.V.

Petrovsky Russian Research Center for Surgery, Moscow, Russia

Fominykh M.V.

Otdelenie kardioreanimatsii i intensivnoĭ terapii FGBU RNTsKh im. akad. B.V. Petrovskogo RAMN, Moskva

Eremenko A.A.

Otdelenie kardioreanimatsii i intensivnoĭ terapii FGBU RNTsKh im. akad. B.V. Petrovskogo RAMN, Moskva

List of references:

  1. Torabi A, Rigby AS, Cleland JGF. Declining In-Hospital Mortality and Increasing Heart Failure Incidence in Elderly Patients With First Myocardial Infarction. J Am CollCardiol. 2009;55(1):79-81. https://doi.org/10.1016/j.jacc.2009.05.080
  2. Huang HW, Brent BN, Shaw RE. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era—a report from the American College of Cardiology-National Cardiovascular data registry (ACC-NCDR). Catheter CardiovascInterv. 2006;68(6):867-872. https://doi.org/10.1002/ccd.20886
  3. Jensen LO, Kaltoft A, Thayssen P, Tilsted HH, Christiansen EH, Mikkelsen KV, Maeng M, Hansen KN, Villadsen AB, Madsen M, others. Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention. Catheter CardiovascInterv. 2010;75(1):101-108. https://doi.org/10.1002/ccd.22205
  4. Burakovsky VI, Barvyn BG. Kardiogennyi shok i ego lechenie kontrpul’satsiei. Kardiologia. 1978;1:9-16 (In Russ.)
  5. Kapur NK, Esposito M. Hemodynamic support with percutaneous devices in patients with heart failure. Heart Failure Clinics. 2015;11(2):215-230. https://doi.org/10.1016/j.hfc.2014.12.012
  6. Eremenko AA, Zyulyaeva TP, Babaev MA, Molochnikov IO, Kolpakov PE. Intraaortic balloon counterpulsation in the treatment of perioperative cardiogenic shock-complicated myocardial infarction during aortocoronary bypass surgery. Anesteziol Reanimatol. 2005;50(2):40-44. (In Russ.)
  7. Schreuder JJ, Castiglioni A, Donelli A, Maisano F, Jansen JR, Hanania R, Hanlon P, Bovelander J, Alfieri O. Automatic intraaortic balloon pump timing using an intrabeat dicrotic notch prediction algorithm. Ann Thorac Surg. 2005;79(3):1017-1022. https://doi.org/10.1016/j.athoracsur.2004.07.074
  8. Papaioannou TG, Stefanadis C. Basic principles of the intraaortic balloon pump and mechanisms affecting its performance. ASAIO Journal. 2005;51(3):296-300. https://doi.org/10.1097/01.MAT.0000159381.97773.9B
  9. Parissis H, Soo A, Al-Alao B. Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump. J Cardiothorac Surg. 2011;6(1):147. https://doi.org/10.1186/1749-8090-6-147
  10. Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, de Belder A, Redwood S, Investigators B-1, others. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA. 2010;304(8):867-874. https://doi.org/10.1001/jama.2010.1190
  11. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, others. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341(9):625.
  12. Abdel-Wahab M, Saad M, Kynast J, Geist V, Sherif MA, Richardt G, Toelg R. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol. 2010;105(7):967-971. https://doi.org/10.1016/j.amjcard.2009.11.021
  13. Thiele H, Schuler G, Neumann F-J, Hausleiter J, Olbrich H-G, Schwarz B, Hennersdorf M, Empen K, Fuernau G, Desch S, others. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J. 2012;163(6):938-945. https://doi.org/10.1016/j.ahj.2012.03.012
  14. Thiele H, Zeymer U, Neumann F-J, Ferenc M, Olbrich H-G, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, others. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. The Lancet. 2013;382(9905):1638-1645. https://doi.org/10.1016/S0140-6736(13)61783-3
  15. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, others. Authors/Task Force members. 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541-2619. https://doi.org/10.1093/eurheartj/ehu278
  16. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, others. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. Catheter Cardiovasc Interv. 2013;82(4):E266-E355. https://doi.org/10.1002/ccd.23390
  17. Perera D, Stables R, Clayton T, De Silva K, Lumley M, Clack L, Thomas M, Redwood S. Long-Term Mortality Data From the Balloon Pump–Assisted Coronary Intervention Study (BCIS-1). Circulation. 2013;127(2):207-212. https://doi.org/10.1161/CIRCULATIONAHA.112.132209
  18. Burkhoff D, Cohen H, Brunckhorst C, O’neill WW, others. A randomized multicenter clinical study to evaluate the safety and efficacy of the Tandem Heart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152(3):469-e1. https://doi.org/10.1016/j.ahj.2006.05.031
  19. Thiele H, Sick P, Boudriot E, Diederich K-W, Hambrecht R, Niebauer J, Schuler G. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. European Heart Journal. 2005;26(13):1276-1283. https://doi.org/10.1093/eurheartj/ehi161
  20. Gilotra NA, Stevens GR. Temporary mechanical circulatory support: a review of the options, indications, and outcomes. Clinical Medicine Insights Cardiology. 2014;8(Suppl 1):75. https://doi.org/10.4137/CMC.S15718
  21. Alli OO, Singh IM, Holmes DR, Pulido JN, Park SJ, Rihal CS. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: The Mayo Clinic experience. Catheter CardiovascInterv. 2012;80(5):728-734. https://doi.org/10.1002/ccd.23465
  22. Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation. 2001;104(24):2917-2922. https://doi.org/10.1161/hc4901.100361
  23. Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011;57(6):688-696. https://doi.org/10.1016/j.jacc.2010.08.613
  24. Sauren LD, Accord RE, Hamzeh K, De Jong M, Van Der Nagel T, Van Der Veen FH, Maessen JG. Combined Impella and Intra-aortic Balloon Pump Support to Improve Both Ventricular Unloading and Coronary Blood Flow for Myocardial Recovery: An Experimental Study. Artificial Organs. 2007;31(11):839-842. https://doi.org/10.1111/j.1525-1594.2007.00477.x
  25. Remmelink M, Sjauw KD, Henriques JP, de Winter RJ, Koch KT, van der Schaaf RJ, Vis MM, Tijssen JG, Piek JJ, Baan J. Effects of left ventricular unloading by Impella recover LP2. 5 on coronary hemodynamics. Catheter Cardiovasc Interv. 2007;70(4):532-537. https://doi.org/10.1002/ccd.21160
  26. Remmelink M, Sjauw KD, Henriques JP, de Winter RJ, Vis MM, Koch KT, Paulus WJ, de Mol BA, Tijssen JG, Piek JJ, others. Effects of mechanical left ventricular unloading by impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients. Catheter Cardiovasc Interv. 2010;75(2):187-194. https://doi.org/10.1002/ccd.22263
  27. Lauten A, Engström AE, Jung C, Empen K, Erne P, Cook S, Windecker S, Bergmann MW, Klingenberg R, Lüscher TF, others. Percutaneous left ventricular support with the Impella 2.5 assist device in acute cardiogenic shock-Results of the Impella EUROSHOCK-Registry. Circulation: Heart Failure. 2012;6(1):23-30. https://doi.org/10.1161/CIRCHEARTFAILURE.112.967224
  28. Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden H-H, Butter C, Engstrøm T, Hassager C, Machado FP, others. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device: the Europella registry. J Am Coll Cardiol. 2009;54(25):2430-2434. https://doi.org/10.1016/j.jacc.2009.09.018
  29. Maini B, Naidu SS, Mulukutla S, Kleiman N, Schreiber T, Wohns D, Dixon S, Rihal C, Dave R, O’neill W. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: The USpella Registry. Catheter Cardiovasc Interv. 2012;80(5):717-725. https://doi.org/10.1002/ccd.23403
  30. O’neill WW, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, Palacios I, Maini B, Mulukutla S, Džavík V, others. A Prospective Randomized Clinical TrЦЦial of Hemodynamic Support with Impella 2.5 TM versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary Intervention: the PROTECT II Study. Circulation. 2012;136(24):1717-1727. https://doi.org/10.1161/CIRCULATIONAHA.112.098194
  31. Cohen MG, Matthews R, Maini B, Dixon S, Vetrovec G, Wohns D, Palacios I, Popma J, Ohman EM, Schreiber T, et al. Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: real-world versus clinical trial experience. Am Heart J. 2015;170(5):872-879. https://doi.org/10.1016/j.ahj.2015.08.009
  32. Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R, Dirschinger J, Kastrati A, Schömig A. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52(19):1584-1588. https://doi.org/10.1016/j.jacc.2008.05.065
  33. Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJ, Vis MM, Wykrzykowska JJ, Koch KT, Baan J, others. Impella CP versus intra-aortic balloon pump in acute myocardial infarction complicated by cardiogenic shock: The IMPRESS trial. J Am Coll Cardiol. 2017;69(3):278-287. https://doi.org/10.1016/j.jacc.2016.10.022
  34. Mariani MA, Diephuis JC, Kuipers MJ, Gianoli M, Grandjean JG. Off-pump coronary artery bypass graft surgery with a pulsatile catheter pump for left ventricular dysfunction. Ann Thorac Surg. 2007;84(2):690-692. https://doi.org/10.1016/j.athoracsur.2006.12.016
  35. Amico A, Brigiani MS, Vallabini A, Ferrante B, Marzovillo A, Loizzi D, Carbone C. PulseCath, a new short-term ventricular assist device: our experience in off-pump coronary artery bypass graft surgery. J Cardiovasc Med. 2008;9(4):423-426. https://doi.org/10.2459/JCM.0b013e3282eee851
  36. Dzemeshkevich SL, Babaev MA, Frolova YuV, Malikova MS, Lugovoy AN, Dombrovskaya AV, Polyak ME, Dymova OV, Eremenko AA, Zaklyazminskaya EV. Non-compaction of the Left Ventricular Myocardium, reverse cardiac remodeling and PulseCath left ventricular assist device. Clinical and Experimental Surgery. Petrovsky journal. 2017;5(1):15-21. (In Russ.)
  37. Anastasiadis K, Chalvatzoulis O, Antonitsis P, Tossios P, Papakonstantinou C. Left ventricular decompression during peripheral extracorporeal membrane oxygenation support with the use of the novel iVAC pulsatile paracorporeal assist device. Ann Thorac Surg. 2011;92(6):2257-2259. https://doi.org/10.1016/j.athoracsur.2011.05.063
  38. Arrigoni SC, Kuijpers M, Mecozzi G, Mariani MA. PulseCath as a right ventricular assist device. Interactive Cardiovascular and Thoracic Surgery. 2011;12(6):891-894. https://doi.org/10.1510/icvts.2010.257576
  39. Van Mieghem NM, Daemen J, Lenzen MJ, Zandstra R, Malkin O, van Geuns RJ. The PulseCath iVAC 2L left ventricular assist device: conversion to a percutaneous transfemoral approach. EuroIntervention. 2015;11(7):835-839. https://doi.org/10.4244/eijv11i7a168
  40. den Uil CA, Daemen J, Lenzen MJ, Maugenest A-M, Joziasse L, van Geuns RJ, Van Mieghem NM. Pulsatile iVAC 2L circulatory support in high-risk percutaneous coronary intervention. EuroIntervention. 2017;12(14):1689-1696. https://doi.org/10.4244/EIJ-D-16-00371
  41. Samol A, Schmidt S, Zeyse M, Dürrwald S, Wiemer M. First high-risk percutaneous coronary intervention under use of the iVAC 2l system in Germany. Future cardiology. 2017;13(2):117-123. https://doi.org/10.2217/fca-2016-0064
  42. Atluri P, Acker MA. Pulsatile left ventricular assist devices: what is the role in the modern era? Seminars in Thoracic and Cardiovascular Surgery. 2010;22(2):106-108. https://doi.org/10.1053/j.semtcvs.2010.09.002
  43. Cheng A, Williamitis CA, Slaughter MS. Comparison of continuous-flow and pulsatile-flow left ventricular assist devices: is there an advantage to pulsatility? Ann Cardiothorac Surg. 2014;3(6):573. https://doi.org/10.3978/j.issn.2225-319X.2014.08.24

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.